Efficacy and Survival of Systemic Psoriasis Treatments: An Analysis of the Swiss Registry SDNTT
Author(s) -
JuliaTatjana Maul,
Vahid Djamei,
Antonios G.A. Kolios,
Barbara Meier,
Justine Czernielewski,
Pascal Jungo,
Nikhil Yawalkar,
Carlo Mainetti,
Emmanuel Laffitte,
C. Spehr,
Mark Anliker,
Markus Streit,
Matthias Augustin,
Stephan Jeff Rustenbach,
Curdin Conrad,
Jürg Hafner,
WolfHenning Boehncke,
Luca Borradori,
Michel Gilliet,
Peter Itin,
Lars E. French,
Peter Häusermann,
Alexander A. Navarini
Publication year - 2016
Publication title -
dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.224
H-Index - 92
eISSN - 1421-9832
pISSN - 1018-8665
DOI - 10.1159/000452740
Subject(s) - medicine , psoriasis , psoriatic arthritis , systemic therapy , plaque psoriasis , dermatology , surgery , cancer , breast cancer
The Swiss psoriasis registry SDNTT (Swiss Dermatology Network for Targeted Therapies) records the long-term safety and effectiveness of systemic treatment regimens for psoriasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom